Pfizer, U.S. ink $5.29 deal over possible COVID-19 treatment
The Associated Press NEW YORK (AP) - The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators…
The Associated Press NEW YORK (AP) - The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators…